Clinical trial
Bariatric Surgery and Pharmacokinetics Fluoxetine: BAR-MEDS Fluoxetine
NCT03476525 is registered in ClinicalTrials.gov with Norwegian University of Science and Technology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bariatric Surgery and Pharmacokinetics Fluoxetine: BAR-MEDS Fluoxetine
- Lead sponsor
- Norwegian University of Science and Technology
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 2, 2016
- Completion date
- October 31, 2026
- Enrollment
- 12 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.